Stelara Patent Deal Puts JandJ Back on Track to Revenue Forecast.

Published Date: 10 Jun 2023

Stelara may contribute more to J&J's 2024 and 2025 sales than Wall Street anticipates thanks to a legal agreement Johnson and Johnson reached with Amgen to postpone the release of a biosimilar version of the popular psoriasis treatment until January 2025.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot